๐Ÿ”Ž Trials Near Me

Home โ€บ Meningioma

Meningioma clinical trials recruiting in the U.S.

29 studies for Meningioma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 10, 2026 ยท NCT03180268

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 8, 2026 ยท NCT04343157

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 8, 2026 ยท NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Sep 2, 2026 ยท NCT04374305

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 2, 2026 ยท NCT02523014

Natural History Study of Patients With Neurofibromatosis Type 2

RecruitingObservational study
Ages 8 to 75 ยท All sexes ยท Updated Sep 1, 2026 ยท NCT00598351

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

Recruiting
Ages 18 and older ยท All sexes ยท Updated Aug 26, 2026 ยท NCT06557512

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 14, 2026 ยท NCT06014905

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 13, 2026 ยท NCT07150806

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Jul 30, 2026 ยท NCT07533942

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

RecruitingObservational study
All ages ยท All sexes ยท Updated Jul 22, 2026 ยท NCT04427384

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

RecruitingPhase 1/2
Ages 4 to 39 ยท All sexes ยท Updated Jul 20, 2026 ยท NCT05278208

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

RecruitingEarly phase 1
Ages 18 and older ยท All sexes ยท Updated Jun 30, 2026 ยท NCT07493447

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

RecruitingObservational study
Ages 18 to 99 ยท All sexes ยท Updated Jun 10, 2026 ยท NCT05576103

Cognitive Status After Removal of Skull Base Meningioma

RecruitingObservational study
Ages 18 to 89 ยท All sexes ยท Updated May 22, 2026 ยท NCT04635657

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated May 19, 2026 ยท NCT07418775

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

RecruitingPhase 1/2
Ages 18 to 90 ยท All sexes ยท Updated May 14, 2026 ยท NCT05636618

Cabozantinib for Patients With Recurrent or Progressive Meningioma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated May 14, 2026 ยท NCT05425004

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Apr 22, 2026 ยท NCT04082520

Abemaciclib in Newly Diagnosed Meningioma Patients

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Mar 13, 2026 ยท NCT05940493

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

RecruitingPhase 4
Ages 18 to 99 ยท All sexes ยท Updated Feb 27, 2026 ยท NCT06377371

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Recruiting
Ages 18 and older ยท All sexes ยท Updated Feb 17, 2026 ยท NCT04278118

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Feb 10, 2026 ยท NCT06132685

Evaluation of the CONVIVO System

Recruiting
Ages 18 and older ยท All sexes ยท Updated Feb 6, 2026 ยท NCT05139277

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.